Astrazeneca
AZN
Astrazeneca (AZN) news
Recent news
CSPC Pharmaceutical - Initiates phase I clinical trial of SYH2092 injection for weight management in China
CSPC Pharmaceutical Group Ltd. has announced the initiation of a Phase I clinical trial for SYH2092 injection, a highly potent amylin receptor agonist, at the first center in China . The trial is part of the company’s broader efforts to develop innovative therapies for weight management and related…
AInvest Wire · 6h agoAstraZeneca - Full results to be shared with regulatory authorities and scientific community
AInvest Wire · 4d agoImportantA AstraZeneca - Tezspire demonstrates positive phase III results in eosinophilic esophagitis
AInvest Wire · 4d agoAstraZeneca India gets Delhi court stay on NPPA demand notice
AInvest Wire · 5d agoAstraZeneca - offering expected to close on September 1, 2026
AInvest Wire · 6d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.